The primary outcome was change in A1C between initiation of colesevelam HCL (i.e., baseline) and three alternative time periods, including 16-weeks (days 42 140), 26-weeks (days 42 210), and 52-weeks (days 42 395) following initiation.
TB-IRIS is more likely to occur in patients with a low baseline CD4 count, a short duration between initiation of antitubercular treatment and cART and disseminated tuberculosis [34], [35], [36].
The median time interval between the baseline scan and initiation of treatment was 5 days (range 1 8), and between initiation of treatment and FLT/PET evaluation was 10 days (range 5 15).
Previously reported risk factors for the development of IRIS include low baseline CD4+ T-cell count, a robust immunologic and virologic response to ART, and a short interval between initiation of treatment for the OI and ART [5], [6], [12].
Although the design did not include a washout period between termination of baseline therapy and initiation of latanoprost/timolol FC combination, this would not be expected to impact the long-term outcomes evaluated herein.
The PTP is indicated by the area below the baseline pressure between the initiation of inspiration and the time for the pressure to return to the baseline.
In the present study, TB-IRIS occurred in 9% of the patients, despite the rather short time interval between the initiation of antituberculous drugs and ART and the low baseline CD4 count, two recognised risk factors [23], [26] [28].
Nine milliliters (mL) of blood were collected in EDTA tubes, in the morning (between 08.30 and 11.00 h), from 173 patients with mCRC before the initiation of the treatment (baseline sample) and from 51 patients during the antiangiogenic treatment with Bev (on-treatment sample, at least 3 weeks after treatment initiation).
The relationship between initiation and progression of substance use.
